Zepp Health Corporation (ZEPP) 10-Year Financial Performance & Capital Metrics

ZEPP • • Industrial / General

TechnologyConsumer ElectronicsWearable TechnologySmart Wearables & Fitness

AboutZepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.Show more

Revenue $1.33B -46.6%
EBITDA -$308M -91.4%
Net Income -$554M -151.3%
EPS (Diluted) -136.64 -1642.9%
Gross Margin 38.46% +46.9%
EBITDA Margin -23.13% -258.6%
Operating Margin -25.88% -199.9%
Net Margin -41.56% -370.7%
ROE -25.52% -197.7%
ROIC -9.85% -91.3%
Debt/Equity 0.72 +29.9%
Interest Coverage -8.51 -88.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 97 (top 3%)
✓Trading at only 0.0x book value

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Sales declining 25.5% over 5 years
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-25.46%

3Y-39.99%

TTM13.95%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-66.61%

EPS CAGR

10Y-

5Y-

3Y-

TTM-160.76%

ROCE

10Y Avg6.35%

5Y Avg-4.17%

3Y Avg-9.73%

Latest-11.83%

Peer Comparison

Smart Wearables & Fitness

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ZEPPZepp Health Corporation	158.46M	22.50	-0.16	-46.61%	-28.52%	-29.73%		0.72

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	925.38M	1.63B	2B	3.79B	5.8B	6.08B	6.17B	4.22B	2.5B	1.33B
Revenue Growth %	-	0.76%	0.23%	0.9%	0.53%	0.05%	0.01%	-0.32%	-0.41%	-0.47%
Cost of Goods Sold+	811.23M	1.34B	1.52B	2.81B	4.33B	4.82B	4.88B	3.4B	1.84B	820.57M
COGS % of Revenue	0.88%	0.82%	0.76%	0.74%	0.75%	0.79%	0.79%	0.81%	0.74%	0.62%
Gross Profit+	114.16M	288.86M	482.26M	976.09M	1.46B	1.26B	1.29B	817.22M	653.7M	512.88M
Gross Margin %	0.12%	0.18%	0.24%	0.26%	0.25%	0.21%	0.21%	0.19%	0.26%	0.38%
Gross Profit Growth %	-	1.53%	0.67%	1.02%	0.5%	-0.14%	0.02%	-0.37%	-0.2%	-0.22%
Operating Expenses+	155.57M	274.86M	304.87M	596.1M	844.74M	1.1B	1.2B	1.23B	869.22M	857.92M
OpEx % of Revenue	0.17%	0.17%	0.15%	0.16%	0.15%	0.18%	0.19%	0.29%	0.35%	0.64%
Selling, General & Admin	92.03M	136.47M	154.91M	322.61M	415.08M	586.59M	687.6M	708.46M	504.69M	520.85M
SG&A % of Revenue	0.1%	0.08%	0.08%	0.09%	0.07%	0.1%	0.11%	0.17%	0.2%	0.39%
Research & Development	63.54M	138.39M	149.96M	273.49M	429.66M	508.64M	508.41M	526.2M	364.53M	337.07M
R&D % of Revenue	0.07%	0.09%	0.08%	0.07%	0.07%	0.08%	0.08%	0.12%	0.15%	0.25%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-41.41M	14M	177.39M	379.99M	619.04M	164.69M	92.73M	-417.45M	-215.52M	-345.04M
Operating Margin %	-0.04%	0.01%	0.09%	0.1%	0.11%	0.03%	0.02%	-0.1%	-0.09%	-0.26%
Operating Income Growth %	-	1.34%	11.67%	1.14%	0.63%	-0.73%	-0.44%	-5.5%	0.48%	-0.6%
EBITDA+	-41.11M	16.51M	181.02M	386.45M	636.21M	190.33M	143.94M	-357.8M	-161.09M	-308.4M
EBITDA Margin %	-0.04%	0.01%	0.09%	0.1%	0.11%	0.03%	0.02%	-0.08%	-0.06%	-0.23%
EBITDA Growth %	-	1.4%	9.97%	1.13%	0.65%	-0.7%	-0.24%	-3.49%	0.55%	-0.91%
D&A (Non-Cash Add-back)	294.19K	2.51M	3.62M	6.46M	17.17M	25.65M	51.21M	59.65M	54.43M	36.64M
EBIT	-40M	30.19M	187.07M	401.69M	650.61M	251.11M	149.59M	-321.07M	-197.31M	-382.3M
Net Interest Income+	263.23K	788.69K	2.93M	12.05M	33.39M	43.6M	-27.83M	-45.45M	-25.93M	-13.73M
Interest Income	263.23K	788.69K	2.93M	12.05M	33.39M	43.6M	16.47M	12.55M	21.86M	26.81M
Interest Expense	0	0	0	0	0	0	44.3M	58M	47.79M	40.54M
Other Income/Expense	1.41M	14.28M	12.42M	23.51M	30.46M	81.93M	53.06M	56.34M	-21.7M	-108.55M
Pretax Income+	-40M	28.28M	189.81M	403.5M	649.5M	246.62M	145.78M	-361.11M	-237.22M	-453.59M
Pretax Margin %	-0.04%	0.02%	0.1%	0.11%	0.11%	0.04%	0.02%	-0.09%	-0.09%	-0.34%
Income Tax+	-925.94K	3.23M	26.92M	54.07M	77.68M	29.45M	10.61M	-67.03M	-17.2M	99.99M
Effective Tax Rate %	0.98%	0.89%	0.86%	0.88%	0.88%	0.88%	0.93%	0.81%	0.93%	1.22%
Net Income+	-39.07M	25.05M	163.46M	353.31M	573.64M	216.27M	136.02M	-293.37M	-220.49M	-554.13M
Net Margin %	-0.04%	0.02%	0.08%	0.09%	0.1%	0.04%	0.02%	-0.07%	-0.09%	-0.42%
Net Income Growth %	-	1.64%	5.53%	1.16%	0.62%	-0.62%	-0.37%	-3.16%	0.25%	-1.51%
Net Income (Continuing)	-39.07M	25.05M	162.89M	349.44M	571.82M	217.17M	135.18M	-294.08M	-220.02M	-553.58M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	2.42M	-1.34M	-3.13M	0	13.08M	12.22M	13.25M	8.31M
EPS (Diluted)+	-78.36	-14.08	2.60	32.48	143.36	8.64	5.24	-10.84	-7.84	-136.64
EPS Growth %	-	0.82%	1.18%	11.49%	3.41%	-0.94%	-0.39%	-3.07%	0.28%	-16.43%
EPS (Basic)	-78.36	-13.96	2.72	34.28	150.44	9.00	5.52	-10.84	-7.84	-136.64
Diluted Shares Outstanding	3.71M	3.71M	3.71M	3.52M	4.04M	4.07M	4.13M	3.85M	3.8M	4.04M
Basic Shares Outstanding	3.71M	3.71M	3.71M	3.5M	3.85M	3.88M	3.94M	3.85M	3.8M	4.04M
Dividend Payout Ratio	-	-	-	-	0.01%	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	519.19M	859.82M	1.3B	2.86B	4.35B	4.82B	3.93B	2.92B	2.24B	1.84B
Cash & Short-Term Investments	221.66M	164.7M	389.72M	1.6B	1.8B	2.29B	1.53B	993.2M	1.03B	815.51M
Cash Only	221.66M	155.46M	375.84M	1.45B	1.78B	2.27B	1.51B	959.38M	995.09M	808.23M
Short-Term Investments	0	9.24M	13.88M	147.65M	17M	23.38M	24.32M	33.82M	36.5M	7.28M
Accounts Receivable	205.49M	498.81M	648.51M	758.51M	1.65B	1.28B	1.09B	857.83M	580.63M	577.66M
Days Sales Outstanding	81.05	111.83	118.51	73.1	103.66	76.65	64.29	74.27	84.86	158.12
Inventory	90.43M	193.59M	257.85M	493.66M	886.35M	1.22B	1.26B	1.01B	601.38M	414.51M
Days Inventory Outstanding	40.69	52.76	62.12	64.09	74.67	92.02	93.91	108.37	119.05	184.38
Other Current Assets	9	10	8	4.48M	1.77M	4.41M	815.05K	3.17M	1.63M	1.7M
Total Non-Current Assets+	9.42M	113.05M	185.57M	401.58M	773.92M	1.07B	2.15B	2.28B	2.26B	2.02B
Property, Plant & Equipment	2.92M	10.8M	29.09M	40.1M	171.18M	275.18M	242.02M	163.79M	111.56M	75.59M
Fixed Asset Turnover	316.54x	150.74x	68.66x	94.46x	33.86x	22.10x	25.49x	25.74x	22.39x	17.64x
Goodwill	0	0	6M	5.94M	5.87M	62.38M	60.98M	65.13M	67.87M	69.93M
Intangible Assets	0	1.22M	5.4M	63.81M	84.84M	144.89M	135.42M	121.53M	69.91M	51.76M
Long-Term Investments	2M	78.05M	86.24M	209.24M	401.76M	443.01M	1.55B	1.67B	1.71B	1.66B
Other Non-Current Assets	8	15	16.46M	7.36M	8.73M	28.1M	19.57M	49.67M	68.7M	33.63M
Total Assets+	528.62M	972.87M	1.48B	3.26B	5.12B	5.89B	6.08B	5.19B	4.5B	3.86B
Asset Turnover	1.75x	1.67x	1.35x	1.16x	1.13x	1.03x	1.01x	0.81x	0.55x	0.35x
Asset Growth %	-	0.84%	0.52%	1.2%	0.57%	0.15%	0.03%	-0.15%	-0.13%	-0.14%
Total Current Liabilities+	277.58M	634.35M	887.52M	1.39B	2.46B	2.78B	2.15B	1.64B	1.1B	1.43B
Accounts Payable	251.85M	524.06M	716.07M	1.07B	1.98B	1.95B	1.32B	450.04M	264.14M	372.8M
Days Payables Outstanding	113.32	142.83	172.51	138.34	166.68	147.37	98.4	48.34	52.29	165.83
Short-Term Debt	0	12.66M	35.66M	38.99M	34.61M	551.58M	550.43M	996.26M	513.98M	765.56M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	15.3M	44.03M	54.49M	99.02M	152.73M	124.49M	146.82M	107.87M	244.39M	232.37M
Current Ratio	1.87x	1.36x	1.46x	2.06x	1.77x	1.73x	1.83x	1.77x	2.04x	1.29x
Quick Ratio	1.54x	1.05x	1.17x	1.70x	1.41x	1.29x	1.24x	1.16x	1.49x	1.00x
Cash Conversion Cycle	8.42	21.76	8.12	-1.15	11.65	21.29	59.8	134.31	151.62	176.67
Total Non-Current Liabilities+	0	44.41M	10.61M	61.29M	80.88M	382.94M	998.75M	900.94M	904.32M	587.54M
Long-Term Debt	0	0	3.11M	0	0	59.87M	726M	674.4M	850.23M	549.17M
Capital Lease Obligations	0	0	0	0	75.54M	115.99M	71.03M	31.24M	22.65M	14.65M
Deferred Tax Liabilities	0	0	2.5M	4.97M	5.34M	22.32M	26.88M	35.04M	29.53M	22.75M
Other Non-Current Liabilities	0	44.41M	5M	56.33M	0	184.76M	174.85M	160.27M	1.91M	970.73K
Total Liabilities	277.58M	634.35M	898.13M	1.45B	2.54B	3.17B	3.15B	2.55B	2B	2.01B
Total Debt+	0	12.66M	38.77M	38.99M	110.15M	727.44M	1.35B	1.7B	1.39B	1.33B
Net Debt	-221.66M	-142.8M	-337.07M	-1.41B	-1.67B	-1.54B	-160.3M	742.51M	391.76M	521.15M
Debt / Equity	-	0.04x	0.07x	0.02x	0.04x	0.27x	0.46x	0.64x	0.55x	0.72x
Debt / EBITDA	-	0.77x	0.21x	0.10x	0.17x	3.82x	9.36x	-	-	-
Net Debt / EBITDA	-	-8.65x	-1.86x	-3.66x	-2.63x	-8.11x	-1.11x	-	-	-
Interest Coverage	-	-	-	-	-	-	2.09x	-7.20x	-4.51x	-8.51x
Total Equity+	251.04M	338.52M	584.55M	1.81B	2.47B	2.72B	2.93B	2.65B	2.5B	1.84B
Equity Growth %	-	0.35%	0.73%	2.1%	0.36%	0.1%	0.08%	-0.1%	-0.06%	-0.26%
Book Value per Share	67.58	91.13	157.36	515.35	611.95	669.68	709.31	687.70	657.78	456.02
Total Shareholders' Equity	251.04M	338.52M	582.13M	1.81B	2.47B	2.72B	2.92B	2.63B	2.49B	1.84B
Common Stock	55.95K	56K	56.66K	151.2K	153.34K	156.65K	158.81K	159.67K	184.19K	189.76K
Retained Earnings	-60.38M	-36.49M	132.73M	340.51M	900.87M	1.13B	1.27B	929.32M	739.23M	208.88M
Treasury Stock	0	0	0	0	0	0	-21.77M	-66.2M	-91.2M	-109.43M
Accumulated OCI	10.22M	15.79M	22.36M	97.27M	109.89M	44.53M	29.24M	104.28M	-99.23M	-293.25M
Minority Interest	0	0	2.42M	-1.34M	-3.13M	0	13.08M	12.22M	13.25M	8.31M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-6.99M	15.28M	229.83M	720.98M	443.55M	150.78M	-331.77M	-117.11M	42.6M	-24.39M
Operating CF Margin %	-0.01%	0.01%	0.12%	0.19%	0.08%	0.02%	-0.05%	-0.03%	0.02%	-0.02%
Operating CF Growth %	-	3.19%	14.04%	2.14%	-0.38%	-0.66%	-3.2%	0.65%	1.36%	-1.57%
Net Income	-39.07M	25.05M	163.46M	353.31M	573.64M	216.27M	136.02M	-43.35M	-31.09M	-75.81M
Depreciation & Amortization	294.19K	2.51M	3.62M	6.46M	17.17M	25.65M	51.21M	8.71M	7.69M	5.02M
Stock-Based Compensation	0	0	0	0	0	0	0	7.27M	8.79M	4.78M
Deferred Taxes	0	0	-18.49M	-34.18M	-27.72M	-9.87M	-18.45M	-9.92M	-2.88M	13.45M
Other Non-Cash Items	57.8M	63.39M	58.16M	139.78M	112.78M	115.18M	119.98M	2.44M	12.21M	20.51M
Working Capital Changes	-26M	-75.67M	23.06M	255.61M	-232.31M	-196.44M	-620.52M	-82.26M	47.88M	7.66M
Change in Receivables	-18.34M	2.32M	-119.82M	-21.09M	-898.56M	427.55M	300.79M	3.13M	43.8M	404K
Change in Inventory	-54.53M	-108.23M	-56.16M	-244.05M	-431.81M	-388.27M	-82.05M	27.92M	51.91M	5.55M
Change in Payables	169.34M	284.52M	177.06M	370.22M	933.32M	-9.23M	-664.51M	-135.34M	-27.82M	14.81M
Cash from Investing+	-5.07M	-103.96M	-37.9M	-337.51M	-112.4M	-195.59M	-1.06B	-6.24M	7.73M	-1.58M
Capital Expenditures	-3.01M	-12.03M	-21M	-71.85M	-46M	-80.15M	-52.39M	-1.21M	-1.6M	-1.4M
CapEx % of Revenue	0%	0.01%	0.01%	0.02%	0.01%	0.01%	0.01%	0%	0%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-16.81M	-14.48M	-108.68M	103.46M	-445.28K	0	-2.57M	3.25M	1.66M
Cash from Financing+	220.97M	13.27M	22.1M	678.33M	8.83M	531.78M	646.39M	42.37M	-41.68M	477K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	-4.53M	0	0	-6.3M	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	241.07M	0	0	0	0	0	0	40.28M	7.82M	4.4M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-9.99M	4.53M	208.91M	703.17M	409.37M	71.79M	-377.22M	-118.59M	40.92M	-25.88M
FCF Margin %	-0.01%	0%	0.1%	0.19%	0.07%	0.01%	-0.06%	-0.03%	0.02%	-0.02%
FCF Growth %	-	1.45%	45.12%	2.37%	-0.42%	-0.82%	-6.25%	0.69%	1.35%	-1.63%
FCF per Share	-2.69	1.22	56.24	199.98	101.39	17.65	-91.32	-30.82	10.77	-6.40
FCF Conversion (FCF/Net Income)	0.18x	0.61x	1.41x	2.04x	0.77x	0.70x	-2.44x	0.40x	-0.19x	0.04x
Interest Paid	0	0	0	0	0	0	0	8.3M	6.26M	89K
Taxes Paid	0	0	0	0	0	0	0	512K	0	62K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-15.57%	8.5%	35.42%	29.48%	26.79%	8.33%	4.81%	-10.52%	-8.57%	-25.52%
Return on Invested Capital (ROIC)	-105.73%	9.33%	60.04%	88.41%	77.8%	12.49%	3.52%	-10.17%	-5.15%	-9.85%
Gross Margin	12.34%	17.74%	24.14%	25.77%	25.25%	20.71%	20.89%	19.39%	26.17%	38.46%
Net Margin	-4.22%	1.54%	8.18%	9.33%	9.9%	3.56%	2.2%	-6.96%	-8.83%	-41.56%
Debt / Equity	-	0.04x	0.07x	0.02x	0.04x	0.27x	0.46x	0.64x	0.55x	0.72x
Interest Coverage	-	-	-	-	-	-	2.09x	-7.20x	-4.51x	-8.51x
FCF Conversion	0.18x	0.61x	1.41x	2.04x	0.77x	0.70x	-2.44x	0.40x	-0.19x	0.04x
Revenue Growth	-	75.94%	22.68%	89.63%	53.04%	4.93%	1.43%	-31.67%	-40.76%	-46.61%

Revenue by Segment

	2017	2018	2019	2020	2021	2022	2023	2024
Manufactured Product, Other	-	-	-	-	-	2.45B	1.85B	-
Manufactured Product, Other Growth	-	-	-	-	-	-	-24.34%	-
Product	-	-	4.19B	4.44B	-	1.7B	644.88M	-
Product Growth	-	-	-	5.83%	-	-	-62.00%	-
Smart Wearable Devices	-	-	-	-	3.34B	-	-	-
Smart Wearable Devices Growth	-	-	-	-	-	-	-	-
Self-branded products and others	-	-	-	-	2.91B	-	-	-
Self-branded products and others Growth	-	-	-	-	-	-	-	-
Manufactured Product Other	-	-	1.62B	2B	-	-	-	-
Manufactured Product Other Growth	-	-	-	23.27%	-	-	-	-
Xiaomi Wearable Products	2.85B	4.32B	-	-	-	-	-	-
Xiaomi Wearable Products Growth	-	51.83%	-	-	-	-	-	-
Self Branded Products And Others	755.79M	2.03B	-	-	-	-	-	-
Self Branded Products And Others Growth	-	168.35%	-	-	-	-	-	-

Revenue by Geography

	2017	2018	2019	2020	2021	2022	2023	2024
Asia Pacific	-	-	-	-	-	-	1.28B	75.53M
Asia Pacific Growth	-	-	-	-	-	-	-	-94.10%
Europe	-	-	-	-	-	-	951.52M	74.88M
Europe Growth	-	-	-	-	-	-	-	-92.13%
North America	-	-	-	-	-	-	234.28M	27.37M
North America Growth	-	-	-	-	-	-	-	-88.32%
UNITED STATES	-	-	-	-	-	-	-	27.19M
UNITED STATES Growth	-	-	-	-	-	-	-	-
Other	-	-	-	-	-	-	29.75M	4.82M
Other Growth	-	-	-	-	-	-	-	-83.81%

Frequently Asked Questions

Growth & Financials

Zepp Health Corporation (ZEPP) reported $1.68B in revenue for fiscal year 2024. This represents a 81% increase from $925.4M in 2015.

Zepp Health Corporation (ZEPP) saw revenue decline by 46.6% over the past year.

Zepp Health Corporation (ZEPP) reported a net loss of $479.1M for fiscal year 2024.

Dividend & Returns

Zepp Health Corporation (ZEPP) has a return on equity (ROE) of -25.5%. Negative ROE indicates the company is unprofitable.

Zepp Health Corporation (ZEPP) had negative free cash flow of $25.9M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Zepp Health Corporation (ZEPP) 10-Year Financial Performance & Capital Metrics

ZEPP • • Industrial / General

TechnologyConsumer ElectronicsWearable TechnologySmart Wearables & Fitness

Revenue $1.33B -46.6%
EBITDA -$308M -91.4%
Net Income -$554M -151.3%
EPS (Diluted) -136.64 -1642.9%
Gross Margin 38.46% +46.9%
EBITDA Margin -23.13% -258.6%
Operating Margin -25.88% -199.9%
Net Margin -41.56% -370.7%
ROE -25.52% -197.7%
ROIC -9.85% -91.3%
Debt/Equity 0.72 +29.9%
Interest Coverage -8.51 -88.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 97 (top 3%)
✓Trading at only 0.0x book value

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Sales declining 25.5% over 5 years
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-25.46%

3Y-39.99%

TTM13.95%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-66.61%

EPS CAGR

10Y-

5Y-

3Y-

TTM-160.76%

ROCE

10Y Avg6.35%

5Y Avg-4.17%

3Y Avg-9.73%

Latest-11.83%

Peer Comparison

Smart Wearables & Fitness

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ZEPPZepp Health Corporation	158.46M	22.50	-0.16	-46.61%	-28.52%	-29.73%		0.72

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	925.38M	1.63B	2B	3.79B	5.8B	6.08B	6.17B	4.22B	2.5B	1.33B
Revenue Growth %	-	0.76%	0.23%	0.9%	0.53%	0.05%	0.01%	-0.32%	-0.41%	-0.47%
Cost of Goods Sold+	811.23M	1.34B	1.52B	2.81B	4.33B	4.82B	4.88B	3.4B	1.84B	820.57M
COGS % of Revenue	0.88%	0.82%	0.76%	0.74%	0.75%	0.79%	0.79%	0.81%	0.74%	0.62%
Gross Profit+	114.16M	288.86M	482.26M	976.09M	1.46B	1.26B	1.29B	817.22M	653.7M	512.88M
Gross Margin %	0.12%	0.18%	0.24%	0.26%	0.25%	0.21%	0.21%	0.19%	0.26%	0.38%
Gross Profit Growth %	-	1.53%	0.67%	1.02%	0.5%	-0.14%	0.02%	-0.37%	-0.2%	-0.22%
Operating Expenses+	155.57M	274.86M	304.87M	596.1M	844.74M	1.1B	1.2B	1.23B	869.22M	857.92M
OpEx % of Revenue	0.17%	0.17%	0.15%	0.16%	0.15%	0.18%	0.19%	0.29%	0.35%	0.64%
Selling, General & Admin	92.03M	136.47M	154.91M	322.61M	415.08M	586.59M	687.6M	708.46M	504.69M	520.85M
SG&A % of Revenue	0.1%	0.08%	0.08%	0.09%	0.07%	0.1%	0.11%	0.17%	0.2%	0.39%
Research & Development	63.54M	138.39M	149.96M	273.49M	429.66M	508.64M	508.41M	526.2M	364.53M	337.07M
R&D % of Revenue	0.07%	0.09%	0.08%	0.07%	0.07%	0.08%	0.08%	0.12%	0.15%	0.25%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-41.41M	14M	177.39M	379.99M	619.04M	164.69M	92.73M	-417.45M	-215.52M	-345.04M
Operating Margin %	-0.04%	0.01%	0.09%	0.1%	0.11%	0.03%	0.02%	-0.1%	-0.09%	-0.26%
Operating Income Growth %	-	1.34%	11.67%	1.14%	0.63%	-0.73%	-0.44%	-5.5%	0.48%	-0.6%
EBITDA+	-41.11M	16.51M	181.02M	386.45M	636.21M	190.33M	143.94M	-357.8M	-161.09M	-308.4M
EBITDA Margin %	-0.04%	0.01%	0.09%	0.1%	0.11%	0.03%	0.02%	-0.08%	-0.06%	-0.23%
EBITDA Growth %	-	1.4%	9.97%	1.13%	0.65%	-0.7%	-0.24%	-3.49%	0.55%	-0.91%
D&A (Non-Cash Add-back)	294.19K	2.51M	3.62M	6.46M	17.17M	25.65M	51.21M	59.65M	54.43M	36.64M
EBIT	-40M	30.19M	187.07M	401.69M	650.61M	251.11M	149.59M	-321.07M	-197.31M	-382.3M
Net Interest Income+	263.23K	788.69K	2.93M	12.05M	33.39M	43.6M	-27.83M	-45.45M	-25.93M	-13.73M
Interest Income	263.23K	788.69K	2.93M	12.05M	33.39M	43.6M	16.47M	12.55M	21.86M	26.81M
Interest Expense	0	0	0	0	0	0	44.3M	58M	47.79M	40.54M
Other Income/Expense	1.41M	14.28M	12.42M	23.51M	30.46M	81.93M	53.06M	56.34M	-21.7M	-108.55M
Pretax Income+	-40M	28.28M	189.81M	403.5M	649.5M	246.62M	145.78M	-361.11M	-237.22M	-453.59M
Pretax Margin %	-0.04%	0.02%	0.1%	0.11%	0.11%	0.04%	0.02%	-0.09%	-0.09%	-0.34%
Income Tax+	-925.94K	3.23M	26.92M	54.07M	77.68M	29.45M	10.61M	-67.03M	-17.2M	99.99M
Effective Tax Rate %	0.98%	0.89%	0.86%	0.88%	0.88%	0.88%	0.93%	0.81%	0.93%	1.22%
Net Income+	-39.07M	25.05M	163.46M	353.31M	573.64M	216.27M	136.02M	-293.37M	-220.49M	-554.13M
Net Margin %	-0.04%	0.02%	0.08%	0.09%	0.1%	0.04%	0.02%	-0.07%	-0.09%	-0.42%
Net Income Growth %	-	1.64%	5.53%	1.16%	0.62%	-0.62%	-0.37%	-3.16%	0.25%	-1.51%
Net Income (Continuing)	-39.07M	25.05M	162.89M	349.44M	571.82M	217.17M	135.18M	-294.08M	-220.02M	-553.58M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	2.42M	-1.34M	-3.13M	0	13.08M	12.22M	13.25M	8.31M
EPS (Diluted)+	-78.36	-14.08	2.60	32.48	143.36	8.64	5.24	-10.84	-7.84	-136.64
EPS Growth %	-	0.82%	1.18%	11.49%	3.41%	-0.94%	-0.39%	-3.07%	0.28%	-16.43%
EPS (Basic)	-78.36	-13.96	2.72	34.28	150.44	9.00	5.52	-10.84	-7.84	-136.64
Diluted Shares Outstanding	3.71M	3.71M	3.71M	3.52M	4.04M	4.07M	4.13M	3.85M	3.8M	4.04M
Basic Shares Outstanding	3.71M	3.71M	3.71M	3.5M	3.85M	3.88M	3.94M	3.85M	3.8M	4.04M
Dividend Payout Ratio	-	-	-	-	0.01%	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	519.19M	859.82M	1.3B	2.86B	4.35B	4.82B	3.93B	2.92B	2.24B	1.84B
Cash & Short-Term Investments	221.66M	164.7M	389.72M	1.6B	1.8B	2.29B	1.53B	993.2M	1.03B	815.51M
Cash Only	221.66M	155.46M	375.84M	1.45B	1.78B	2.27B	1.51B	959.38M	995.09M	808.23M
Short-Term Investments	0	9.24M	13.88M	147.65M	17M	23.38M	24.32M	33.82M	36.5M	7.28M
Accounts Receivable	205.49M	498.81M	648.51M	758.51M	1.65B	1.28B	1.09B	857.83M	580.63M	577.66M
Days Sales Outstanding	81.05	111.83	118.51	73.1	103.66	76.65	64.29	74.27	84.86	158.12
Inventory	90.43M	193.59M	257.85M	493.66M	886.35M	1.22B	1.26B	1.01B	601.38M	414.51M
Days Inventory Outstanding	40.69	52.76	62.12	64.09	74.67	92.02	93.91	108.37	119.05	184.38
Other Current Assets	9	10	8	4.48M	1.77M	4.41M	815.05K	3.17M	1.63M	1.7M
Total Non-Current Assets+	9.42M	113.05M	185.57M	401.58M	773.92M	1.07B	2.15B	2.28B	2.26B	2.02B
Property, Plant & Equipment	2.92M	10.8M	29.09M	40.1M	171.18M	275.18M	242.02M	163.79M	111.56M	75.59M
Fixed Asset Turnover	316.54x	150.74x	68.66x	94.46x	33.86x	22.10x	25.49x	25.74x	22.39x	17.64x
Goodwill	0	0	6M	5.94M	5.87M	62.38M	60.98M	65.13M	67.87M	69.93M
Intangible Assets	0	1.22M	5.4M	63.81M	84.84M	144.89M	135.42M	121.53M	69.91M	51.76M
Long-Term Investments	2M	78.05M	86.24M	209.24M	401.76M	443.01M	1.55B	1.67B	1.71B	1.66B
Other Non-Current Assets	8	15	16.46M	7.36M	8.73M	28.1M	19.57M	49.67M	68.7M	33.63M
Total Assets+	528.62M	972.87M	1.48B	3.26B	5.12B	5.89B	6.08B	5.19B	4.5B	3.86B
Asset Turnover	1.75x	1.67x	1.35x	1.16x	1.13x	1.03x	1.01x	0.81x	0.55x	0.35x
Asset Growth %	-	0.84%	0.52%	1.2%	0.57%	0.15%	0.03%	-0.15%	-0.13%	-0.14%
Total Current Liabilities+	277.58M	634.35M	887.52M	1.39B	2.46B	2.78B	2.15B	1.64B	1.1B	1.43B
Accounts Payable	251.85M	524.06M	716.07M	1.07B	1.98B	1.95B	1.32B	450.04M	264.14M	372.8M
Days Payables Outstanding	113.32	142.83	172.51	138.34	166.68	147.37	98.4	48.34	52.29	165.83
Short-Term Debt	0	12.66M	35.66M	38.99M	34.61M	551.58M	550.43M	996.26M	513.98M	765.56M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	15.3M	44.03M	54.49M	99.02M	152.73M	124.49M	146.82M	107.87M	244.39M	232.37M
Current Ratio	1.87x	1.36x	1.46x	2.06x	1.77x	1.73x	1.83x	1.77x	2.04x	1.29x
Quick Ratio	1.54x	1.05x	1.17x	1.70x	1.41x	1.29x	1.24x	1.16x	1.49x	1.00x
Cash Conversion Cycle	8.42	21.76	8.12	-1.15	11.65	21.29	59.8	134.31	151.62	176.67
Total Non-Current Liabilities+	0	44.41M	10.61M	61.29M	80.88M	382.94M	998.75M	900.94M	904.32M	587.54M
Long-Term Debt	0	0	3.11M	0	0	59.87M	726M	674.4M	850.23M	549.17M
Capital Lease Obligations	0	0	0	0	75.54M	115.99M	71.03M	31.24M	22.65M	14.65M
Deferred Tax Liabilities	0	0	2.5M	4.97M	5.34M	22.32M	26.88M	35.04M	29.53M	22.75M
Other Non-Current Liabilities	0	44.41M	5M	56.33M	0	184.76M	174.85M	160.27M	1.91M	970.73K
Total Liabilities	277.58M	634.35M	898.13M	1.45B	2.54B	3.17B	3.15B	2.55B	2B	2.01B
Total Debt+	0	12.66M	38.77M	38.99M	110.15M	727.44M	1.35B	1.7B	1.39B	1.33B
Net Debt	-221.66M	-142.8M	-337.07M	-1.41B	-1.67B	-1.54B	-160.3M	742.51M	391.76M	521.15M
Debt / Equity	-	0.04x	0.07x	0.02x	0.04x	0.27x	0.46x	0.64x	0.55x	0.72x
Debt / EBITDA	-	0.77x	0.21x	0.10x	0.17x	3.82x	9.36x	-	-	-
Net Debt / EBITDA	-	-8.65x	-1.86x	-3.66x	-2.63x	-8.11x	-1.11x	-	-	-
Interest Coverage	-	-	-	-	-	-	2.09x	-7.20x	-4.51x	-8.51x
Total Equity+	251.04M	338.52M	584.55M	1.81B	2.47B	2.72B	2.93B	2.65B	2.5B	1.84B
Equity Growth %	-	0.35%	0.73%	2.1%	0.36%	0.1%	0.08%	-0.1%	-0.06%	-0.26%
Book Value per Share	67.58	91.13	157.36	515.35	611.95	669.68	709.31	687.70	657.78	456.02
Total Shareholders' Equity	251.04M	338.52M	582.13M	1.81B	2.47B	2.72B	2.92B	2.63B	2.49B	1.84B
Common Stock	55.95K	56K	56.66K	151.2K	153.34K	156.65K	158.81K	159.67K	184.19K	189.76K
Retained Earnings	-60.38M	-36.49M	132.73M	340.51M	900.87M	1.13B	1.27B	929.32M	739.23M	208.88M
Treasury Stock	0	0	0	0	0	0	-21.77M	-66.2M	-91.2M	-109.43M
Accumulated OCI	10.22M	15.79M	22.36M	97.27M	109.89M	44.53M	29.24M	104.28M	-99.23M	-293.25M
Minority Interest	0	0	2.42M	-1.34M	-3.13M	0	13.08M	12.22M	13.25M	8.31M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-6.99M	15.28M	229.83M	720.98M	443.55M	150.78M	-331.77M	-117.11M	42.6M	-24.39M
Operating CF Margin %	-0.01%	0.01%	0.12%	0.19%	0.08%	0.02%	-0.05%	-0.03%	0.02%	-0.02%
Operating CF Growth %	-	3.19%	14.04%	2.14%	-0.38%	-0.66%	-3.2%	0.65%	1.36%	-1.57%
Net Income	-39.07M	25.05M	163.46M	353.31M	573.64M	216.27M	136.02M	-43.35M	-31.09M	-75.81M
Depreciation & Amortization	294.19K	2.51M	3.62M	6.46M	17.17M	25.65M	51.21M	8.71M	7.69M	5.02M
Stock-Based Compensation	0	0	0	0	0	0	0	7.27M	8.79M	4.78M
Deferred Taxes	0	0	-18.49M	-34.18M	-27.72M	-9.87M	-18.45M	-9.92M	-2.88M	13.45M
Other Non-Cash Items	57.8M	63.39M	58.16M	139.78M	112.78M	115.18M	119.98M	2.44M	12.21M	20.51M
Working Capital Changes	-26M	-75.67M	23.06M	255.61M	-232.31M	-196.44M	-620.52M	-82.26M	47.88M	7.66M
Change in Receivables	-18.34M	2.32M	-119.82M	-21.09M	-898.56M	427.55M	300.79M	3.13M	43.8M	404K
Change in Inventory	-54.53M	-108.23M	-56.16M	-244.05M	-431.81M	-388.27M	-82.05M	27.92M	51.91M	5.55M
Change in Payables	169.34M	284.52M	177.06M	370.22M	933.32M	-9.23M	-664.51M	-135.34M	-27.82M	14.81M
Cash from Investing+	-5.07M	-103.96M	-37.9M	-337.51M	-112.4M	-195.59M	-1.06B	-6.24M	7.73M	-1.58M
Capital Expenditures	-3.01M	-12.03M	-21M	-71.85M	-46M	-80.15M	-52.39M	-1.21M	-1.6M	-1.4M
CapEx % of Revenue	0%	0.01%	0.01%	0.02%	0.01%	0.01%	0.01%	0%	0%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-16.81M	-14.48M	-108.68M	103.46M	-445.28K	0	-2.57M	3.25M	1.66M
Cash from Financing+	220.97M	13.27M	22.1M	678.33M	8.83M	531.78M	646.39M	42.37M	-41.68M	477K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	-4.53M	0	0	-6.3M	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	241.07M	0	0	0	0	0	0	40.28M	7.82M	4.4M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-9.99M	4.53M	208.91M	703.17M	409.37M	71.79M	-377.22M	-118.59M	40.92M	-25.88M
FCF Margin %	-0.01%	0%	0.1%	0.19%	0.07%	0.01%	-0.06%	-0.03%	0.02%	-0.02%
FCF Growth %	-	1.45%	45.12%	2.37%	-0.42%	-0.82%	-6.25%	0.69%	1.35%	-1.63%
FCF per Share	-2.69	1.22	56.24	199.98	101.39	17.65	-91.32	-30.82	10.77	-6.40
FCF Conversion (FCF/Net Income)	0.18x	0.61x	1.41x	2.04x	0.77x	0.70x	-2.44x	0.40x	-0.19x	0.04x
Interest Paid	0	0	0	0	0	0	0	8.3M	6.26M	89K
Taxes Paid	0	0	0	0	0	0	0	512K	0	62K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-15.57%	8.5%	35.42%	29.48%	26.79%	8.33%	4.81%	-10.52%	-8.57%	-25.52%
Return on Invested Capital (ROIC)	-105.73%	9.33%	60.04%	88.41%	77.8%	12.49%	3.52%	-10.17%	-5.15%	-9.85%
Gross Margin	12.34%	17.74%	24.14%	25.77%	25.25%	20.71%	20.89%	19.39%	26.17%	38.46%
Net Margin	-4.22%	1.54%	8.18%	9.33%	9.9%	3.56%	2.2%	-6.96%	-8.83%	-41.56%
Debt / Equity	-	0.04x	0.07x	0.02x	0.04x	0.27x	0.46x	0.64x	0.55x	0.72x
Interest Coverage	-	-	-	-	-	-	2.09x	-7.20x	-4.51x	-8.51x
FCF Conversion	0.18x	0.61x	1.41x	2.04x	0.77x	0.70x	-2.44x	0.40x	-0.19x	0.04x
Revenue Growth	-	75.94%	22.68%	89.63%	53.04%	4.93%	1.43%	-31.67%	-40.76%	-46.61%

Revenue by Segment

	2017	2018	2019	2020	2021	2022	2023	2024
Manufactured Product, Other	-	-	-	-	-	2.45B	1.85B	-
Manufactured Product, Other Growth	-	-	-	-	-	-	-24.34%	-
Product	-	-	4.19B	4.44B	-	1.7B	644.88M	-
Product Growth	-	-	-	5.83%	-	-	-62.00%	-
Smart Wearable Devices	-	-	-	-	3.34B	-	-	-
Smart Wearable Devices Growth	-	-	-	-	-	-	-	-
Self-branded products and others	-	-	-	-	2.91B	-	-	-
Self-branded products and others Growth	-	-	-	-	-	-	-	-
Manufactured Product Other	-	-	1.62B	2B	-	-	-	-
Manufactured Product Other Growth	-	-	-	23.27%	-	-	-	-
Xiaomi Wearable Products	2.85B	4.32B	-	-	-	-	-	-
Xiaomi Wearable Products Growth	-	51.83%	-	-	-	-	-	-
Self Branded Products And Others	755.79M	2.03B	-	-	-	-	-	-
Self Branded Products And Others Growth	-	168.35%	-	-	-	-	-	-

Revenue by Geography

	2017	2018	2019	2020	2021	2022	2023	2024
Asia Pacific	-	-	-	-	-	-	1.28B	75.53M
Asia Pacific Growth	-	-	-	-	-	-	-	-94.10%
Europe	-	-	-	-	-	-	951.52M	74.88M
Europe Growth	-	-	-	-	-	-	-	-92.13%
North America	-	-	-	-	-	-	234.28M	27.37M
North America Growth	-	-	-	-	-	-	-	-88.32%
UNITED STATES	-	-	-	-	-	-	-	27.19M
UNITED STATES Growth	-	-	-	-	-	-	-	-
Other	-	-	-	-	-	-	29.75M	4.82M
Other Growth	-	-	-	-	-	-	-	-83.81%

Frequently Asked Questions

Growth & Financials

Zepp Health Corporation (ZEPP) reported $1.68B in revenue for fiscal year 2024. This represents a 81% increase from $925.4M in 2015.

Zepp Health Corporation (ZEPP) saw revenue decline by 46.6% over the past year.

Zepp Health Corporation (ZEPP) reported a net loss of $479.1M for fiscal year 2024.

Dividend & Returns

Zepp Health Corporation (ZEPP) has a return on equity (ROE) of -25.5%. Negative ROE indicates the company is unprofitable.

Zepp Health Corporation (ZEPP) had negative free cash flow of $25.9M in fiscal year 2024, likely due to heavy capital investments.